Project Details
Description
Production of high purity isotopes by mass separation proposes to federate a consortium of the key European intense neutron sources, isotope mass separation facilities and high-power accelerators and cyclotrons, with leading biomedical research institutes and hospitals active in the translation of the emerging radionuclides into medical diagnosis and treatment
Key findings
nuclear medicine, isotope, radionuclide, radiopharmaceutical
| Short title | PRISMAP |
|---|---|
| Status | Finished |
| Effective start/end date | 1/05/21 → 30/04/25 |
| Links | https://www.prismap.eu/ |
Collaborative partners
- Rīga Stradiņš University
- University of Latvia (lead)
UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This project contributes towards the following SDG(s):
-
SDG 9 Industry, Innovation, and Infrastructure
Keywords
- nuclear medicine
- radionuclide
- radiopharmaceutical
Field of Science
- 3.2 Clinical medicine
- 3.4 Medical biotechnology
- 1.4 Chemical sciences
- 3.3 Health sciences
- 1.3 Physical sciences
Smart Specialization Area
- Biomedicine, medical technologies and biotechnology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Research output
- 1 Commissioned report
-
Deliverable 5.1 - Questionnaire on industrial and clinical key players and needs (v1.0).
Radzina, M. (Corresponding Author), Mamis, E., Saule, L., Pajuste, E., Kalniņa, M., Cocolios, T., Talip, Z. & Stora, T., 30 Sept 2022, 60 p.Research output: Book/Report › Commissioned report › Research › peer-review
Open AccessFile68 Downloads (Pure)